OTLK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
<p>New York, New York - <a href="https://www.newsfilecorp.com/">Newsfile Corp.</a> - December 30, 2023 - <b>WHY: </b>Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, both dates inclusive (the "Class Period"), of the important <b>January 2, 2024 lead plaintiff deadline</b>.</p>